Filing search / Intra-Cellular Therapies, Inc. / "R&D" / Page 3

8-K

EX-99.1

wjmmsdfglghnr

12 Aug 14

Company announces successful End-of Phase 2 meeting with the FDA and Phase 3 plans for ITI-007 for schizophrenia

12:00am

424B3

akvlev1dhq3i

4 Apr 14

Prospectus supplement

12:00am

8-K

EX-99.1

m9ursu4i u79qq6p

25 Mar 14

Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2013 Financial Results

12:00am

424B1

jm8tffzd

31 Jan 14

Prospectus with pricing info

12:00am

424B3

dbxnn7ay4k9w16s0ngp

19 Dec 13

Prospectus supplement

12:00am

S-1

s4df70

18 Sep 13

IPO registration

12:00am

8-K

EX-99.1

pd8zoj

5 Sep 13

Report of Independent Registered Public Accounting Firm

12:00am